GST show cause notice for FY23, potential Rs 11.11 Cr impact
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts less than Nifty Microcap 250 and 4.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Artemis Medicare Services received a GST show cause notice from CGST Gurugram dated Sep 28, 2026 for FY 2022-23. The department alleges the company charged MRP including GST on medicines, consumables and implants from in-patients but did not remit the GST. Potential impact is Rs 11.11 Crore plus interest and penalty. The company is filing a writ at Punjab and Haryana High Court to connect with an earlier writ where stay was granted.
Rs 11.11 Cr plus interest/penalty exposure if stay not extended. Earlier similar matter has High Court stay, which is positive.